ZCMD vs. GMDAQ, NH, SNOA, NOVN, NIVF, AGRX, CYTO, QNRX, EIGR, and DYNT
Should you be buying Zhongchao stock or one of its competitors? The main competitors of Zhongchao include Gamida Cell (GMDAQ), NantHealth (NH), Sonoma Pharmaceuticals (SNOA), Novan (NOVN), NewGenIvf Group (NIVF), Agile Therapeutics (AGRX), Altamira Therapeutics (CYTO), Quoin Pharmaceuticals (QNRX), Eiger BioPharmaceuticals (EIGR), and Dynatronics (DYNT). These companies are all part of the "medical" sector.
Zhongchao (NASDAQ:ZCMD) and Gamida Cell (NASDAQ:GMDAQ) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability, risk and media sentiment.
Zhongchao has a beta of 0.31, suggesting that its stock price is 69% less volatile than the S&P 500. Comparatively, Gamida Cell has a beta of 0.93, suggesting that its stock price is 7% less volatile than the S&P 500.
1.7% of Zhongchao shares are owned by institutional investors. Comparatively, 50.3% of Gamida Cell shares are owned by institutional investors. 28.6% of Zhongchao shares are owned by insiders. Comparatively, 6.7% of Gamida Cell shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Zhongchao has higher revenue and earnings than Gamida Cell.
In the previous week, Zhongchao had 2 more articles in the media than Gamida Cell. MarketBeat recorded 2 mentions for Zhongchao and 0 mentions for Gamida Cell. Zhongchao's average media sentiment score of 0.59 beat Gamida Cell's score of 0.00 indicating that Zhongchao is being referred to more favorably in the media.
Zhongchao and Gamida Cell both received 0 outperform votes by MarketBeat users.
Summary
Zhongchao beats Gamida Cell on 6 of the 9 factors compared between the two stocks.
Get Zhongchao News Delivered to You Automatically
Sign up to receive the latest news and ratings for ZCMD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ZCMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Zhongchao Competitors List
Related Companies and Tools